Clinical Trial Update: [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/Phase 2 study evaluating an [18F]FPyQCP PET imaging agent targeting fibroblast activation protein across colorectal cancer, ovarian cancer, g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Gastric Cancer
• Ovarian Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• [18F]FPyQCP (fluorine-18 labeled fibroblast activation protein-targeting PET radiotracer (FPyQCP))

Snippet

Sponsor: Blue Earth Diagnostics | Conditions: Colorectal Cancer, Epithelial Ovarian Cancer | Phase 1, Phase 2 | Status: RECRUITING